Comparison of Patient Survival According to Erythropoiesis-Stimulating Agent Type of Treatment in Maintenance Hemodialysis Patients

This study aimed to evaluate the difference in patient survival according to the type of erythropoiesis-stimulating agent (ESA) treatment used in the Korean hemodialysis (HD) population. This retrospective study analyzed the laboratory data from a national HD quality assessment program and the claim...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seok Hui, Kim, Bo Yeon, Son, Eun Jung, Kim, Gui Ok, Do, Jun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861937/
https://www.ncbi.nlm.nih.gov/pubmed/36675553
http://dx.doi.org/10.3390/jcm12020625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861937/
https://www.ncbi.nlm.nih.gov/pubmed/36675553
http://dx.doi.org/10.3390/jcm12020625

Ejemplares similares